PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 64 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,487 | +26.2% | 11,700 | -29.9% | 0.00% | +100.0% |
| Q2 2023 | $2,764 | -87.2% | 16,700 | -24.8% | 0.00% | -90.9% |
| Q1 2023 | $21,667 | -4.0% | 22,200 | +2.3% | 0.01% | -15.4% |
| Q4 2022 | $22,568 | -48.7% | 21,700 | -43.0% | 0.01% | -51.9% |
| Q3 2022 | $44,000 | -70.3% | 38,070 | -52.1% | 0.03% | -69.7% |
| Q2 2022 | $148,000 | -39.3% | 79,400 | -1.2% | 0.09% | -21.9% |
| Q1 2022 | $244,000 | -26.1% | 80,400 | -7.9% | 0.11% | -16.8% |
| Q4 2021 | $330,000 | – | 87,300 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |